Explain this page
Arphra AIPlain-English read on Bio-Rad Laboratories, Inc.’s valuation06-03today
- BIO-key Receives Notice of Non-Compliance from Nasdaq Related to Delay of its Form 10-Q Filing4d
- BIO-key Receives Notice of Non-Compliance from Nasdaq Related to Delay of its Form 10-Q Filing4d
- BIO GREEN MED SOLUTION, INC. ANNOUNCES BUSINESS COMBINATION AGREEMENT TO ACQUIRE FUTURE NRG SDN.10d
- BIO GREEN MED SOLUTION, INC. ANNOUNCES BUSINESS COMBINATION AGREEMENT TO ACQUIRE FUTURE NRG SDN.10d
AI Issuer Brief
Arphra AILoading cached brief…
Fair value
Football field →Weighted blend
$258.36
-9.65% vs spot
Recommendation
Underweight
16 of 17 methods
Method spread
2bull10bear
±5% threshold
Analyst PT consensus: $321.67 (+12.50%)
Price change · trailing returns
Live| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -2.22% | -3.42% | +15.52% | +8.81% | -7.14% | -5.63% | +23.41% | -24.57% | -53.07% | +102.56% | +11129.64% |
Insider · 30d
History →Bought
$0
0 txns
Sold
$0
0 txns
Net flow
+$0
Aftermarket
LiveLast trade
$285.94
613 sh
Bid
$240.00
6 sh
Ask
$319.99
40 sh
Spread
$79.990
Recent quarters
All financials →| Period | Revenue | Net income | EPS |
|---|---|---|---|
| Q1 Mar 2026 | $592.1M | -$527.1M | $-19.55 |
| Q4 Dec 2025 | $693.2M | $720M | $26.65 |
| Q3 Sep 2025 | $653M | -$341.9M | $-12.70 |
| Q2 Jun 2025 | $651.6M | $317.8M | $11.67 |
| Q1 Mar 2025 | $585.4M | $64M | $2.29 |
| Q4 Dec 2024 | $667.48M | -$715.8M | $-25.57 |
Sector & industry today
LiveSectors
- Utilities+2.58%
- Energy+1.31%
- Basic Materials+0.81%
- Consumer Defensive+0.72%
- Technology+0.67%
- Real Estate+0.47%
- Financial Services+0.33%
- Industrials+0.06%
- Consumer Cyclical-0.34%
- Communication Services-0.77%
- Healthcare-1.62%
Top industries (issuer's industry highlighted)
- Medical - Devices+0.05%
- Broadcasting-4.06%
- Coal+3.67%
- Renewable Utilities+3.61%
- Silver+3.21%
- Computer Hardware+2.54%
- Medical - Equipment & Services-2.31%
- Oil & Gas Energy+2.30%
- Auto - Dealerships-2.28%
- Copper+2.24%
- Drug Manufacturers - General-2.21%
- Medical - Healthcare Information Services-2.20%
Analyst view
Consensus target
—
No price-target data returned for this ticker.
Recent actions
0 ↑0 ↓0 hold
- No recent grade actions.
News
DB · news_items- BIO-key Receives Notice of Non-Compliance from Nasdaq Related to Delay of its Form 10-Q Filingglobenewswire.com·Jun 10, 2026
- BIO-key Receives Notice of Non-Compliance from Nasdaq Related to Delay of its Form 10-Q Filingglobenewswire.com·Jun 10, 2026
- BIO GREEN MED SOLUTION, INC. ANNOUNCES BUSINESS COMBINATION AGREEMENT TO ACQUIRE FUTURE NRG SDN.globenewswire.com·Jun 04, 2026
- BIO GREEN MED SOLUTION, INC. ANNOUNCES BUSINESS COMBINATION AGREEMENT TO ACQUIRE FUTURE NRG SDN.globenewswire.com·Jun 04, 2026
- BIO-key's RedChip Future Tech Investor Conference Presentation to be Webcast Wed. June 10 at 3pm ETglobenewswire.com·Jun 04, 2026
- BIO-key's RedChip Future Tech Investor Conference Presentation to be Webcast Wed. June 10 at 3pm ETglobenewswire.com·Jun 04, 2026
- Bio-Rad Laboratories, Inc. (BIO) Presents at Jefferies Global Healthcare Conference 2026 Transcriptseekingalpha.com·Jun 03, 2026
- Lexaria Attending the BIO International Convention, as part of a Broader Business Development Programthenewswire.com·Jun 03, 2026
Peers
No peer list available for BIO.
Total assets
$10.58B
Total debt
$1.53B
Cash & equiv
$531.8M
Operating CF
$532.2M
Free cash flow
$374.6M
Buybacks
-$295.5M
Recent insiders
All →| Insider | Action | Shares | Value | Date |
|---|---|---|---|---|
| No open-market insider activity in the recent window. | ||||
Income statement · annual
5y| Period | Revenue | Op income | Net income | EPS | Net margin |
|---|---|---|---|---|---|
| FY 2025 | $2.58B | $270.5M | $759.9M | $27.87 | +29.42% |
| FY 2024 | $2.57B | $269M | -$1.84B | $-65.36 | -71.86% |
| FY 2023 | $2.67B | $337.8M | -$637.32M | $-21.82 | -23.86% |
| FY 2022 | $2.8B | $482.62M | -$3.63B | $-121.79 | -129.45% |
| FY 2021 | $2.92B | $500.34M | $4.25B | $140.83 | +145.57% |